2013
DOI: 10.1016/j.fertnstert.2012.10.048
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers in uterine leiomyoma

Abstract: Biomarkers are biologic compounds that are easily accessible and reflect normal physiology or pathology. They are useful in a variety of clinical situations that involve detection of subclinical disease, risk stratification, preoperative planning, and monitoring treatment. A useful intervention needs to exist for a biomarker to be an effective tool. Many compounds have been investigated as potential biomarkers for the diagnosis and surveillance of uterine leiomyomas. Most of these compounds demonstrate subtle … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
31
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(33 citation statements)
references
References 59 publications
2
31
0
Order By: Relevance
“…Based on the multiplied value of the AUC and a cross‐validation score, the best combination was determined, which consisted of two miRNAs (miR‐191‐5p and miR‐1246), and the diagnostic index (DI) of the model was defined as (DI = (−0.479) × miR‐191‐5p + (−0.380) × miR‐1246 + 6.386). When distinguishing all US subtypes from benign ULM controls, the diagnostic performance of the model was higher than that of serum lactate dehydrogenase (LDH), which is a major conventional biomarker for US (model‐AUC: 0.83 [0.65‐1.00], and LDH‐AUC: 0.62 [0.38‐0.85]) (Figure ). Notably, when focusing on ULMS screening, the accuracy was much higher and the difference from the LDH level was more significant (model‐AUC: 0.97 [0.91‐1.00], and LDH‐AUC: 0.64 [0.34‐0.94]) (Figure A).…”
Section: Resultsmentioning
confidence: 99%
“…Based on the multiplied value of the AUC and a cross‐validation score, the best combination was determined, which consisted of two miRNAs (miR‐191‐5p and miR‐1246), and the diagnostic index (DI) of the model was defined as (DI = (−0.479) × miR‐191‐5p + (−0.380) × miR‐1246 + 6.386). When distinguishing all US subtypes from benign ULM controls, the diagnostic performance of the model was higher than that of serum lactate dehydrogenase (LDH), which is a major conventional biomarker for US (model‐AUC: 0.83 [0.65‐1.00], and LDH‐AUC: 0.62 [0.38‐0.85]) (Figure ). Notably, when focusing on ULMS screening, the accuracy was much higher and the difference from the LDH level was more significant (model‐AUC: 0.97 [0.91‐1.00], and LDH‐AUC: 0.64 [0.34‐0.94]) (Figure A).…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, Sakaguchi et al [18] showed that coordinated expression of ERα and ERβ might be necessary for normal estrogen action in myometrium [19]. In addition, it has been shown ERα is phosphorylated at a higher rate on serine in leiomyoma compared with surrounding myometrium, for that reason it is possible that phosphorylated ERα regulated by p44/42 MAPK, will have a role in development of uterine leiomyoma [20,21].…”
Section: Discussionmentioning
confidence: 95%
“…Our patient had no clinical or radiological ascites, and given her previous history of laparoscopic myomectomy, we did not consider measuring the tumor markers, because the mass was unlikely to be malignant. However, in cases of suspected malignancy such as leiomyosarcoma, tumor markers may be useful in monitoring therapy and follow-up, especially if initially elevated [ 15 ].…”
Section: Discussionmentioning
confidence: 99%